CS.Stealth.IFU Rev 08 12/17
Stealth™ Cervical Spacer System
Instruction for Use
Implants
General Description:
The STEALTH™ Cervical Spacer System consists of intervertebral body fusion
devices (“interbody spacers”) comprised of polyetheretherketone (PEEK-OPTIMA®
polymer, Invibio®) with tantalum markers (ASTM F2026 and ASTM F560,
respectively). The spacers have a basic oval shape that coincides with the shape of
vertebral bodies, a hollow center for placement of bone graft, and angled ridges,
or “teeth,” on both the superior and inferior surfaces for resisting migration. They
are available in an assortment of heights and in multiple angles of lordosis to
accommodate different anatomic requirements.
Indications for Use:
The STEALTH Cervical Spacer System is intended for anterior cervical spine
intervertebral body fusion at one level from the C2-C3 disc space to the C7-T1 disc
for the treatment of degenerative disc disease (DDD) in skeletally mature patients
who have had six (6) weeks of non-operative treatment. DDD is defined as neck
pain of discogenic origin with degeneration of the disc confirmed by history and
radiographic studies. The device system is to be used with supplemental fixation
and with autograft to facilitate fusion.
Contraindications:
Contraindications for the STEALTH Cervical Spacer System are similar to those of
other systems of similar design, and include, but are not limited to:
1. Active infectious process in the patient, particularly in or adjacent to the
spine or spinal structures
2. Conditions, such as morbid obesity, which may put excessive stress on the
bone and implants
3. Severe osteopenia or osteoporosis may prevent adequate fixation
4. Suspected or documented metal allergy
5. Use of these implants is relatively contraindicated in patients whose
activity, mental capacity, mental illness, alcohol or drug abuse, occupation
or life-style may interfere with their ability to follow post-operative
instructions
6. Pregnancy
Warnings:
1. Mixing of dissimilar metals can accelerate the corrosion process. Stainless
steel and titanium implants must NOT be used together in building a
construct.
2. A satisfactory outcome is enhanced by the selection of the appropriate
device size and angle.
3. The Stealth Cervical Spacer System has not been evaluated for safety and
compatibility in the MR environment. It has not been tested for heating
and migration in the MR environment.
Precautions:
1. The STEALTH Cervical Spacer System should be implanted only by surgeons
who are fully experienced in the use of such implants and the required
specialized spinal surgery techniques as this is a technically demanding
procedure.
2. The spacers should not be reused even if they appear in a perfect state. Any
spacer that has been used, twisted, bent, implanted and then removed,
even if it appears intact, must be discarded.
3. The STEALTH Cervical Spacer System is used to augment the development
of a spinal fusion by providing temporary stabilization.
The device (spacer) is not intended to be the sole means of spinal support.
Supplemental internal fixation must be used. Bone grafting must be part of
the spinal fusion procedure. If fusion is delayed or does not occur, material
fatigue may cause breakage of the implant. Damage to the implant during
surgery (i.e., scratches, notches) and loads from weight bearing and activity
will affect the implant’s longevity.
4. Refrain from handling the STEALTH Cervical Spacers as much as possible
before implantation, and always handle it with the utmost care. STEALTH
Cervical Spacers (in their original packaging) must be stored with care in a
clean and dry place away from radiation or extreme temperatures. Should
these requirements not be followed, reduced mechanical properties may
occur which could lead to implant failure in some cases.
Preoperative:
1. Preoperative instructions to the patient are essential. The patient should be
made aware of the limitations of the device and the potential adverse
effects of the surgery.
2. Only patients that meet the criteria described in the indications should be
selected.
3. Patient conditions and/or predispositions such as those mentioned in the
contraindications should be avoided.
4. The type of construct to be assembled for the case should be determined
prior to beginning the surgery. An adequate inventory of sizes should be
available at the time of surgery.
Intraoperative:
1. The surgeon must be fully conversant with all aspects of the surgical
technique.
2. Proper function of the surgical instruments specific to the STEALTH Cervical
Spacer System should be verified prior to every surgical procedure.
3. The appropriate type and size of implant for the patient and the positioning
of the implant are important.
Postoperative:
1. Patients must be informed of the precautions to be taken in their everyday
life to enhance a maximum implant service life.
2. Regular post-operative follow-up is recommended to detect early signs of
implant failure and consider necessary action.
Potential Complications and Adverse Effects:
Potential complications and adverse effects for this system are similar to those of
other spinal instrumentation systems, and include, but are not limited to:
1. Early or late loosening of the components
2. Disassembly, bending or breakage of any or all of the components
3. Foreign body (allergic) reaction to the implants
4. Infection
5. Loss of neurological function, including paralysis, spinal cord impingement or
damage
6. Dural tears, CSF leak or fistula or meningitis
7. Bone graft donor complications, including pain, fracture or wound healing
problems
8. Vascular damage resulting in excessive bleeding and malpositioned devices
adjacent to large vessels could cause vessel erosion and catastrophic bleeding.
9. Loss or impairment of bowel, sexual, and/or bladder function and other types
of urological compromise
10. Possible local or systemic adverse reactions from potential long-term
degradation of the polymer or mechanical grinding causing wear debris
11. Bone loss due to resorption or stress shielding
12. Pseudoarthrosis
13. Death
Additional surgery may be necessary to correct some of these potential adverse
effects.